# Chronic Kidney Disease Antidepressant Sertraline Trial

> **NCT00946998** · PHASE3 · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 201 (actual)

## Conditions studied

- Chronic Kidney Disease
- Depression

## Interventions

- **DRUG:** Sertraline
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00946998
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02-08
- **Primary completion:** 2016-11-23
- **Final completion:** 2017-11
- **Target enrollment:** 201 (ACTUAL)
- **Last updated:** 2018-03-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00946998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00946998, "Chronic Kidney Disease Antidepressant Sertraline Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00946998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*